Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Amortizatization of Intangibles (2021 - 2024)

Inmune Bio's Amortizatization of Intangibles history spans 4 years, with the latest figure at $152000.0 for Q4 2024.

  • For Q4 2024, Amortizatization of Intangibles rose 237.78% year-over-year to $152000.0; the TTM value through Dec 2024 reached $79000.0, down 64.73%, while the annual FY2024 figure was $79000.0, 64.73% down from the prior year.
  • Amortizatization of Intangibles for Q4 2024 was $152000.0 at Inmune Bio, up from -$131000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $152000.0 in Q4 2024 and bottomed at -$131000.0 in Q3 2024.
  • The 4-year median for Amortizatization of Intangibles is $55000.0 (2022), against an average of $46571.4.
  • The largest annual shift saw Amortizatization of Intangibles soared 325.0% in 2023 before it tumbled 342.59% in 2024.
  • A 4-year view of Amortizatization of Intangibles shows it stood at $57000.0 in 2021, then skyrocketed by 163.16% to $150000.0 in 2022, then tumbled by 70.0% to $45000.0 in 2023, then skyrocketed by 237.78% to $152000.0 in 2024.
  • Per Business Quant, the three most recent readings for INMB's Amortizatization of Intangibles are $152000.0 (Q4 2024), -$131000.0 (Q3 2024), and $24000.0 (Q2 2024).